UAE Approves Pill for Vitiligo Treatment
The UAE has become the first country in the world to approve an oral treatment for non-segmental vitiligo, offering a … Read More The post UAE Approves Pill for Vitiligo Treatment appeared first on ProPakistani .
The United Arab Emirates has made history by becoming the first country to approve an oral medication for treating non-segmental vitiligo, a skin condition characterized by white patches caused by the destruction of pigment-producing melanocytes. The Emirates Drug Establishment has granted RINVOQ (upadacitinib), a new therapeutic indication, for adults and adolescents aged 12 and above who require systemic treatment for this autoimmune disorder.
Vitiligo, which is not contagious and can affect various body parts, may be more noticeable in individuals with darker skin tones. While existing treatments include topical medications, phototherapy, and laser therapies, the approval of RINVOQ introduces an oral systemic option for eligible patients. The approval underscores the UAE's commitment to leveraging scientific advancements, enhancing its pharmaceutical sector, and accelerating access to innovative therapies.
The regulatory body emphasized the importance of early diagnosis and appropriate treatment selection for those noticing unusual skin color changes, urging them to consult specialists.
Written by urgent.news from ProPakistani's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
